Sangamo Therapeutics Inc (NASDAQ:SGMO)

3.53
Delayed Data
As of Nov 29
 +0.07 / +2.02%
Today’s Change
3.12
Today|||52-Week Range
8.76
-52.93%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Biogen Inc
Sale8/29/2022400,000$5.33$2.1M-32.57%
Biogen Inc
Sale12/23/202181,187$8.55$694.1K-58.74%
Biogen Inc
Sale8/30/2022100,000$5.27$527.0K-33.58%
Macrae Alexander D
Sale2/25/202249,890$5.90$294.4K-40.00%
Biogen Inc
Sale12/09/202123,660$8.56$202.5K-56.51%
Ramelmeier R Andrew /sangamo/
EVP-Technical Operations
Sale2/25/202212,388$5.90$73.1K-40.00%
Mcclung Mark D
Chief Operating Officer & EVP
Sale6/25/202211,525$4.31$49.7K-17.10%
Fontenot Jason D
Senior Vice President & Chief Scientific Officer
Sale2/25/20226,248$5.90$36.9K-40.00%
Mcclung Mark D
Chief Operating Officer & EVP
Sale2/25/20224,610$5.90$27.2K-40.00%
Markels John H
Director
Buy6/03/20226,784$3.69$25.0K-4.84%
Page of 4